NCT07822503

Brief Summary

Acute appendicitis is one of the most common surgical emergencies globally. While surgical removal of the appendix (appendectomy) is the definitive treatment, the optimal surgical approach-laparoscopic versus open-remains widely debated, particularly in obese patients. Obese individuals present unique surgical challenges due to increased abdominal wall thickness, which often necessitates larger skin incisions during open procedures, potentially increasing postoperative pain, wound healing times, and wound complications. This study aims to compare the postoperative outcomes of laparoscopic appendectomy versus standard open appendectomy in obese patients (BMI ≥ 30 kg/m²) presenting with acute appendicitis. Participants will be randomly assigned to undergo either open appendectomy or laparoscopic appendectomy. The primary outcomes evaluated will be the incidence of surgical site infections (including superficial wound infections and intra-abdominal abscesses) up to 30 days post-procedure and the total length of hospital stay (in days).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Oct 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Apr 2027

First Submitted

Initial submission to the registry

September 9, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 16, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

October 2, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

September 16, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 9, 2026

Last Update Submit

September 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of Surgical Site Infection (SSI)

    Proportion of patients who develop a surgical site infection, defined as either superficial/deep wound infection (presence of purulent discharge, erythema, localized swelling, or requiring reopening) or intra-abdominal abscess (confirmed via ultrasound in patients presenting with abdominal pain, fever, or fullness)

    Up to 30 days postoperatively

  • Length of Hospital Stay

    The total number of days the patient remained in the hospital postoperatively until meeting discharge criteria (afebrile, tolerating a regular diet, and achieving good pain control).

    From day of surgery up to discharge (up to 30 days postoperatively)

Study Arms (2)

Open Appendectomy

ACTIVE COMPARATOR

Participants undergo open appendectomy using a standard grid-iron incision under general anesthesia. Appendiceal base ligation and closure are performed in standard anatomical layers.

Procedure: Open Appendectomy

Group 2: Laparoscopic Appendectomy

EXPERIMENTAL

Participants undergo laparoscopic appendectomy using a standard 3-port technique (umbilical, left iliac fossa, and lower midline ports) under general anesthesia.

Procedure: Laparoscopic Appendectomy

Interventions

Open surgical removal of the appendix performed via a standard grid-iron incision under general anesthesia with standard prophylactic antibiotics.

Open Appendectomy

Laparoscopic surgical removal of the appendix using a standard 3-port configuration (umbilical, left iliac fossa, and lower midline ports) under general anesthesia with standard prophylactic antibiotics.

Group 2: Laparoscopic Appendectomy

Eligibility Criteria

Age15 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Obese patients with Body Mass Index (BMI) ≥ 30 kg/m².
  • Clinical diagnosis of acute appendicitis based on Alvarado score (history of right lower quadrant or periumbilical pain shifting to RLQ, nausea and/or vomiting, fever \> 38 °C, RLQ guarding and tenderness, and/or leukocytosis \> 10,000 cells/mL).
  • Age between 15 and 50 years.
  • Both male and female patients.

You may not qualify if:

  • Immunocompromised patients (e.g., HIV infection or current steroid therapy).
  • History of prior chemotherapy, radiotherapy, or recurrent infections.
  • History of drug or alcohol abuse.
  • Severe hepatic, renal, or cardiovascular dysfunction.
  • History of previous abdominal surgery.
  • Appendicular malignancy.
  • Pregnant women.
  • Preoperative findings indicating appendiceal perforation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AppendicitisDiseaseObesity

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

September 9, 2026

First Posted

September 16, 2026

Study Start

October 2, 2026

Primary Completion (Estimated)

April 2, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

September 16, 2026

Record last verified: 2026-09